PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage

Internal Medicine

Volumn 50, Issue 22, 2011, Pages 2775-2781

  Kurata, Tomoko ^a   Kametaka, Satsuki ^a   Ohta, Yasuyuki ^a   Morimoto, Nobutoshi ^a   Deguchi, Shoko ^a   Deguchi, Kentaro ^a   Ikeda, Yoshio ^a   Takao, Yoshiki ^b   Ohta, Taisei ^c   Manabe, Yasuhiro ^d   Sato, Shuhei ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Kurashiki Heisei Hospital   (Japan)

^c Subaru Health Insurance Society Ota Memorial Hospital   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION OKAYAMA MEDICAL CENTER   (Japan)

Author keywords

Ethyl cysteinate dimmer single photon emission computed tomography; Frontal eye field; Multiple system atrophy; Parkinson's disease; Progressive supranuclear palsy

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; EXTRAOCULAR MUSCLE; FALLING; FEMALE; FRONTAL LOBE; HEART; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MIDBRAIN TEGMENTUM ATROPHY; MULTIPLE SYSTEM ATROPHY PARKINSONISM; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTOKINETIC NYSTAGMUS; PARKINSON DISEASE; PARKINSONISM; PROGRESSIVE SUPRANUCLEAR PALSY; TEGMENTUM;

3-IODOBENZYLGUANIDINE; AGED; AGED, 80 AND OVER; BASAL GANGLIA; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; CYSTEINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEURODEGENERATIVE DISEASES; ORGANOTECHNETIUM COMPOUNDS; PARKINSON DISEASE; PARKINSONIAN DISORDERS; RADIOPHARMACEUTICALS; SUPRANUCLEAR PALSY, PROGRESSIVE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 81155138948     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5954     Document Type: Article

References (26)

1. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. Arch Neurol 10: 333-359, 1964.
2. Rebeiz JJ, Kolodny EH, Richardson EP. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18: 20-33, 1968.
3. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 54: S15-S19, 2003.
4. Parkinson J. An Essay on Shaking Palsy. Sherwood, Neely and Jones, London, 1817.
5. Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosung Psychiatry 32: 28-34, 1969.
6. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71: 670-676, 2008.
7. Kurata T, Hayashi T, Murakami T, et al. Differentiation of PA from early PSP with different patterns of symptoms and CBF reduction. Neurol Res 30: 860-867, 2008.
8. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 17: 427-442, 1967.
9. Varrone A, Pagani M, Salvatore E, et al. Identification by [99mTc] ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease. Eur J Nucl Med Mol Imaging 34: 1071-1081, 2007.
10. Williams DR, Watt HC, Lees AJ. Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study. J Neuro Neurosung Psychiatry 77: 468-473, 2006.
11. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry 58: 167-173, 1995.
12. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Rechardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 60: 615-620, 1996.
13. Verny M, Jellinger KA, Hauw JJ, et al. Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathol 91: 427-431, 1996.
14. Rivaud-Pechoux S, Vidailhet M, Gallouedec G, et al. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology 54: 1029-1032, 2000.
15. Diroma C, Dell'Aquila C, Fraddosio A, et al. Natural history and clinical features of progressive supranuclear palsy: a clinical study. Neurol Sci 24: 176-177, 2003.
16. Nath U, Ben-Shlomo Y, Thomson RG, et al. Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology 60: 910-916, 2003.
17. Cordato NJ, Pantelis C, Halliday GM, et al. Frontal atrophy correlates with behavioral changes in progressive supranuclear palsy. Brain 125: 789-800, 2002.
18. Groschel K, Hayser TK, Luft A, et al. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. NeuroImage 21: 714-724, 2004.
19. Oba H, Yagishita A, Terada H, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 64: 2050-2055, 2005.
20. Yoshita M. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci 155: 60-67, 1998.
21. Taki J, Nakajima K, Hwang EH, et al. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 27: 566-573, 2000.
22. Kashihara K, Ohno M, Kawada S, et al. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies. J Nucl Med 47: 1099-1101, 2006.
23. Brodmann K. Vergleichende Lokalisationslehre der Groβhirnrinde in ihren Prinzipien dargestellt auf Grund des Zellaufbaus. Barth, Leipzig 1909; Neudruck 1925 (in German).
24. Pierrot-Deseilligny C, Muri RM, Ploner CJ, et al. Cortical control of ocular saccades in humans: a model for motricity. Prog Brain Res 142: 3-17, 2003.
25. Pierrot-Deseilligny C, Milea D, Muri RM. Eye movement control by the cerebral cortex. Curr Opin Neurol 17: 17-25, 2004.
26. Van Laere K, Versijpt J, Audenaert K, et al. 99mTc-ECD brain perfusion SPECT: variability, asymmetry and effects of age and gender in healthy adults. Eur J Nucl Med 28: 873-887, 2001.